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1. Introduction 
Microsomal l~onooxygenase activity has been 
found frequently to depart from Mic~elis-Menten 
kinetics in that Lineweaver-Burk plots for the oxida- 
tion of a number of xenobiotics have exhibited down- 
wards curvature at high substrate concentrations 
[l-4]. These results are consistent with catalysis 
being effected by more than one enzyme, each with 
a different IS,, value, and this possibility has received 
some support in the finding that endop~asmic reti- 
culum contains multiple monooxygenases [2,3,5]. 
Such kinetic behaviour could however be due to a 
single enzyme possessing multiple interacting sites 
]6,7] and it has been proposed that microsom~ 
monooxygenase activity may be regulated by a ligand 
concentration-dependent mechanism exhibiting nega- 
tive cooperativity [8]. 
Here, we have shown that Michaeiis-Lenten kine- 
tics did not describe the kinetics of O-demethylation 
of p-nitroanisole by a rat liver microsomal prepara- 
tion when enzyme activity was measured over a 1300- 
fold range of substrate concentration. In addition, 
results of studies with 3 competitive inhibitors pre- 
cluded multiple independent catalytic sites as the 
source of the observed non-Michaelian kinetics of 
ether cleavage thereby lending support to the hypo- 
thesis that negative cooperativity may be a feature of 
the control of microsomal monooxygenase activity. 
2. Method and results 
The animals used in these studies were sexually 
mature, normal, male Wistar rats supplied by the 
University Central Animal Breeding Facility. They 
were fed a stock laboratory diet then starved for 1 
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day prior to sacrifice by decapitation. Microsomal 
suspensions were prepared from their livers by the 
method in [9] and the protein concentration of each 
preparation was determined by the Folin-phenol 
method [lo]. Aliquots of each preparation were 
dispensed into polyethylene vials, frozen in liquid 
nitrogen and stored at -75°C until required for use 
in the studies of monooxygenase kinetics. Mono- 
oxygenase activity was determined spectrophoto- 
metrically at 430 nm by following the O-demethyla- 
tion of ~-nitroanisole using a method developed 
from that in 1111. Measurements were carried out 
at 37°C using a Varian Superscan 3 twin-beam record- 
ing spectrophotometer set at 1 .O nm spectral band- 
width and a full scale deflection of 0.1 absorbance 
units. This demethylation reaction is a useful method 
for monitoring monooxygenase activity as the prod- 
uct, p-nitrophenol, has a high molar absorptivity 
(10 277) which permits accurate determination of 
initial rates at low substrate concentrations. More- 
over, O-demethylation of this substrate is the only 
reaction catalysed by monooxygenase which obviates 
the complexities of interpreting reaction kinetics 
where this is not the case [ 121. The major modifica- 
tions which were made to the original method were 
the omission of nicotinamide from the reaction mix- 
ture and the inclusion of NADP in both blank and 
sample cuvettes. The reasons for making these 
changes to such an assay system have been discussed 
[ 131 and the details of the method used are in the 
legend to fig. 1. At a high [substrate] the reaction rate 
was proportional to [protein] over 0.25-2.0 mg/ml 
and all subsequent studies of monooxygenase kinetics 
were carried out at 1 mg protein~ml and with sub- 
strates 2.7 &M-3.6 mM: 2.7 f*M being the minimum 
value at which an accurate measurement could be 
made of the reaction rate and 3.6 mM being con- 
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Fig.1. Scatchard analysis of rat-liver monooxygenase catalysed CJ-demethylation of p-mtroanisoie. All monooxygenase assays were 
done at 37°C in a 3.7 mi total vol. in 1 cm pathlength stoppered matched quartz cuvettes. Both blank and sample reaction mtx- 
tures contained M/l5 phosphate buffer (pH 7.9). 2.5 mM glucose (j-phosphate, 100 nM NADP, p-nitroanisole at 2.7 PM-3.6 mM 
and 1 ~1 (0.14 U) glucose 6-phosphate:NADP oxidoreductase (EC 1.1.1.49). thts last component being added to the sample 
cuvette only. In the assays where the effect of chloramphenicol on monooxygenasc activity was determined aliquots of a 4.5 mM 
stock solution of the antibiotic, prepared in the M/l5 phosphate buffer, were dispensed into both blank and sanrple cuvettes 
together with these other reaction components. Similar stock solutions of phenacetin and ~-methoxybenzaldehyde were used in 
the same way when their inhibitory effects were being determined. After equilibration at 37°C to allow for generation of 
reduced NADP in the sample cuvette the O-demethylation reactton was started by the stmultaneous addition. and thorough mix- 
ing, of equal aliquots of stock microsomal suspension to both blank and sample cuvettes to give a final cont. 1 .O mg protein/ml. 
AI1 the solutions of reagents were prepared fresh for use each day and were maintained in equilibrium with room air, and held at 
room temperature except those of NADP and glucose 6-phosphate which were stored on ice. and that of p-nitroanisole which was 
maintained at 37’C in a water bath. The linear increases in absorbance were recorded over 3-5 min periods, and these rates were 
converted to rates of change of molarity ofp-nitrophenol using the value of 10 277 obtained for its molar absorptivity under these 
assay condttions. Each point is the mean of at least 3 assays. the standard error of each point being contained within its dimen- 
sions. (a) shows results obtained using monooxygenase prep. 1 with no additions (G) and in the present of 0.1 mM chloramphe- 
nicd (A) or 0.25 mM phenacetin (0). (b) shows results obtained using monooxygcnase prep. 2 with no additions (0) and in the 
presence of 50 IJM p-methoxybenzaldehyde (a). Best-fit lines usmg the appropriate parameter values in tables 1 and 2 are shown. 
strained by the solubility of the substrate. tions of these results were that catalysis was being 
The non-Michaelian kinetic behaviour of the effected either by a minimum of 2 non-interacting 
monooxygenase-catalysed O-demethylation of catalytic sites with widely differing Km values, or by 
p-nitroanisole is clearly evident from the data depicted at least 2 interacting sites exhibiting negative coopera- 
by o in fig.la,b. which present the results in the form tivity. Inhibition studies were undertaken to deter- 
of a Scatchard [ 141 plot for 2 separate rat liver micro- mine which of these possibilities was responsible for 
somal preparations. The 2 most plausible explana- the observed kinetic properties. 
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Table I 
The effects of chloramphenicol and phenacetm on the kinetic parameters of microsomal 
O-demethylase activity 
Inhibitor I’ maxi ‘ma, ‘total 
(PM mm-‘. ml-‘. mg irotein-‘) * SEM 
app. K 
(MM) %M 
~PP. K 
(mM) (mM) trn&M 
0 0.387 + 0.011 0.668 i 0.019 1.053 + 0.022 2.35 * 0.341 0.896 ?- 0.094 
Chloram- 
phenicol 
0.10 0.264 + 0.016 0.883 * 0.029 1.14 * 0.031 2.14 f 0.915 0.969 + 0.126 
0.30 0.195 f 0.013 1.214 i- 0.079 1.40 1- 0.084 1.36 ? 0.921 1.69 + 0.252 
0.50 0.160 + 0.014 1.250 + 0.106 1.41 * 0.110 1.62 * 1 22 1.84 t 0.332 
Phenacetin 
0.25 0.218 * 0.020 0.832 + 0.022 1.05 ? 0.024 4.79 * 2.03 0.669 r 0.084 
0.50 0.125 + 0.022 0.885 + 0 032 1.01 + 0.035 1.90? 3.15 0.732 i 0.109 
Equation (I), whrch represents the sum of two hyperbohc relatronships, was fitted to each substrate 
saturation curve to yield the values and standard errors shown in the table. Fitting was performed 
using a non-lmear regression program based on the Gauss-Newton method. The program was written 
in FORTRAN and was run on a PDP-I 1/03-L computer. The values for the parameters represent the 
slopes and intercepts of the asymptotes to the curves shown in fig.la. as well as other curves which, 
for clartty, are not shown in the figure 
Table 2 
The effect of p-methoxybenzaldehyde on the kinetic parameters of mtcrosomal O-demethylase 
activity 
Inhibitor v **ax, V max, vtotal app. Km, app. K 
(/.W (PM min.‘. ml-’ mg protein-‘) + SEM CPM) f SEM (mM) km&M 
0 0.667 r 0.025 0.869 ? 0.058 1.54 + 0.062 5.88 t 0.799 1.33 * 0.310 
50 0.502 _+ 0.037 1.107 _+ 0.010 1.60 _+ 0.039 15.14 f 3.068 1.72 f 0.527 
Equatron (11, whrch represents he sum of two hyperbolic relationships, was fitted to each substrate 
saturation curve to yield the values and standard errors shown in the table. Fitting was performed 
using a non-linear regression program based on the Gauss-Newton method. The program was written 
in FORTRAN and was run on a PDP-11/03-L computer. The values for the parameters represent the 
slopes and intercepts of the asymptotes to the curves shown in fig.lb 
Substrate saturation curves were determined in the 
presence of 3 inhibitors of monooxygenase activity; 
chloramphenicol (A, fig. 1 a), phenacetin (0, fig.1 a) and 
p-methoxybenzaldehyde (b, fig. 1 b). Each saturation 
curve, as well as others not depicted in fig.1, were 
analysed by fitting eq. (1) to the data: 
v s 
ma1 
v,,s 
2 
y=-+- 
Km, +s Km, +s 
(1) 
using the Gauss-Newton method of non-linear regres- 
sion. The resulting values and standard errors for 
V maxl 2 Vmax,, Km and Km for all the kinetic studies 1 2 
undertaken are given in tables 1 and 2. The lines in 
fig.1 are the best fit lines based on these parameter 
values. In all cases a good fit was obtained which 
indicated that eq. (1) represents an accurate descrip- 
tion of the data. 
3. Discussion and conclusions 
Rat liver monooxygenase exhibits non-Michaelian 
kinetic behaviour when catalyzing the oxidative 
U-demethylation of p-nitroanisole (0, fig.la,b). The 
kinetic behaviour which is seen is qualitatively con- 
sistent with catalysis by a minimum of 2 independent 
6.5 
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enzymes with widely different Km values or by a 
single enzyme with >l site which interact in a nega- 
tively cooperative fashion. In the absence of added 
inhibitors the data are described well as the sum of ‘2 
hyperbolic relationships (eq. (1)) but this fact does 
not necessarily imply that there are 2 independent 
enzymes: negative cooperativlty between interacting 
sites on a single enzyme will yield a saturation curve 
with the same general form as eq. (1). We have sought 
to use inhibitors of monooxygenase to distinguish 
between these possibilities. 
Since chloramphenicol and phenacetin are sub- 
strates for monooxygenase [.5 ,151. and p-methoxy- 
benzaldehyde has a close structural similarity to 
p-nitroanisole. these 4 compounds would be expected 
to be mutual competitive ifiibitors of monooxygen- 
ase activity. Thus, if 2 independent enzymes were 
responsible for catalysis, it would be expected that 
the presence of a competitive inhibitor would 
increase the app. Km of one or both enzymes without 
affecting the V m;ty values. In fact, the consistent 
observation is a decrease in v,, and an increase in 
V nlay2. The Km values are also afiected but no regular 
pattern can be discerned. For example, chloramphen- 
icol had no significant effect on K,, but caused an 
increase in K,, while p-methoxybenzaldehyde 
caused Km, to’increase without affecting Km . The 
decrease in V,, might be explained by a nonfcompe- 
titive componeht in the inhibition but it is more 
difficult to interpret the apparent activation of the 
high-K, form of monooxygenase. The most reason- 
able comprehensive explanation of these observations 
would be that the enzyme possesses everal active 
sites which exhibit negatively cooperative interactions 
and that the peculiar effect which these inhibitors 
appear to have on V,, is symptomatic of the fact 
that the data have been &ted to the wrong model. 
Data similar to those shown in fig.1 which were 
obtained in the absence of inhibitor, have previously 
been reported for the oxidation of a number of xeno- 
biotics [l-4] and in some cases [2,3] the results 
have been used in support of the argument that sev- 
eral different enzymes may have been responsible for 
catalysing the metabolism of those substrates. From 
these results with p-nitroanisole it would appear that 
this should be regarded as only one possible explana- 
tion for the observed kinetics of monoox)rgenase 
activity, and that corroborative evidence would be 
needed to establish its validity in each case. Appar- 
ently different forms of cytochrome P450 have been 
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isolated from rat liver microsomes [ 16,171, which 
indicates that endoplasmic reticulum probably does 
contain multiple monooxygenases. These findings 
do not however rule out the possibility that cooper- 
ativity may be a feature of monooxygenase activity 
with respect to some particular substrates. 
The suggestion that monooxygenase activity may 
show cooperative interactions came first as an expla- 
nation for the results of studies on the competitive 
inhibition of the metabolism of a number of xenobio- 
tics [8]. In [ 181, for example, it was shown that 
catalysis of N-demethylation of ethylmorphine was 
competitively inhibited by phenobarbital, chlorpro- 
mazine, zoxazolamine, phenylbutazone and acetani- 
lide; in [ 191, a number of steroids were shown to 
competitively inhibit the oxidation of phenobarbital 
and ethylmorphine and in [8], octane and aniline 
were both shown to competitively inhibit benzphe- 
tamine metabolism. Since these interactions were 
demonstrated with such markedly different chemical 
types of compound it was suggested that a common 
enzyme showing poor substrate specificity was 
involved and it was proposed [8] that monooxygen- 
ase activity may be due to multiple catalytic sites 
which also act as effector sites conferring allosteric 
control of the negatively cooperative type over sub- 
strate oxidation. While we do not fully accept this 
interpretation, these results support the basic pro- 
posal that rat liver microsomal monooxygenase may 
contain multiple sites which interact to yield nega- 
tively cooperative kinetics. Clearly more work is 
required to clarify the number, nature and interac- 
tions of the ligand binding sites of monooxygenase 
and continuing studies m this laboratory are directed 
to this end. 
An early report [30] that chloramphenicol is a 
non-competitive inhibitor of rat liver microsomal 
monooxygenase activity can be rationalized in the 
light of information given in table 1 and &la. In 
that study acetanilide was used as the model xeno- 
biotic substrate for measuring monooxygenase activ- 
ity over the narrow and low substrate range of 4-16 
PM. From table 1 it is apparent that when inhibition 
by chloramphenicol of monooxygenase activity is 
examined under analogous conditions with p-nitroani- 
sole as substrate the antibiotic does appear to pro- 
duce non-competitive inhibition kinetics as app. K, 
1 
is largely unaffected while V,,+ is significantly 
decreased. It is clear from this that the absolute sub- 
strate concentration can have a marked effect on the 
Volume 119. number 1 FEBS LETTERS September 1980 
apparent kinetics of inhibition of monooxygenase 
activity and a wide substrate concentration range 
should be employed to yield the most meaningful and 
informative results. 
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